You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
It is indicated for the treatment of the following infections due to susceptible strains of sensitive organisms. Note: Therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. However, in emergency cases where the causative organism has not been identified, therapy with amoxycillin may be useful. Clinical judgement will decide whether combination with another antibiotic would provide a sufficiently broad spectrum of activity pending sensitivity test results. Skin and skin structure: staphylococcus, non-penicillinase producing; Streptococcus; E. coli (see section 5.1 pharmacodynamic Properties - Microbiology). Respiratory (acute and chronic): H. influenzae; Streptococcus; Strep. pneumoniae; Staphylococcus, non-penicillinase producing; E. coli (see section 5.1 pharmacodynamic Properties - Microbiology). Genitourinary tract (complicated and uncomplicated, acute and chronic): E.coli (see section 5.1 pharmacodynamic Properties - Microbiology), P. mirabilis and Strep. faecalis. Gonorrhoea: N.gonorrhoeae (non-penicillinase producing). Prophylaxis of endocarditis: Amoxycillin may be used for the prophylaxis of bacterial endocarditis in individuals at particular risk, such as those with a prosthetic heart valve or those who have previously had endocarditis.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on July, 1 2025. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
This medicine is generally considered safe during pregnancy if taken as directed. During pregnancy, you should discuss your medicine use with your doctor or pharmacist.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
It is indicated for the treatment of the following infections due to susceptible strains of sensitive organisms. Note: Therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. However, in emergency cases where the causative organism has not been identified, therapy with amoxycillin may be useful. Clinical judgement will decide whether combination with another antibiotic would provide a sufficiently broad spectrum of activity pending sensitivity test results. Skin and skin structure: staphylococcus, non-penicillinase producing; Streptococcus; E. coli (see section 5.1 pharmacodynamic Properties - Microbiology). Respiratory (acute and chronic): H. influenzae; Streptococcus; Strep. pneumoniae; Staphylococcus, non-penicillinase producing; E. coli (see section 5.1 pharmacodynamic Properties - Microbiology). Genitourinary tract (complicated and uncomplicated, acute and chronic): E.coli (see section 5.1 pharmacodynamic Properties - Microbiology), P. mirabilis and Strep. faecalis. Gonorrhoea: N.gonorrhoeae (non-penicillinase producing). Prophylaxis of endocarditis: Amoxycillin may be used for the prophylaxis of bacterial endocarditis in individuals at particular risk, such as those with a prosthetic heart valve or those who have previously had endocarditis.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on July, 1 2025. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
This medicine is generally considered safe during pregnancy if taken as directed. During pregnancy, you should discuss your medicine use with your doctor or pharmacist.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
INDICATIONS: It is indicated for the treatment of the following infections due to susceptible strains of sensitive organisms. Note. Therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. However, in emergency cases where the causative organism has not been identified, therapy with amoxycillin may be useful. Clinical judgement will decide whether combination with another antibiotic would provide a sufficiently broad spectrum of activity pending sensitivity test results. Skin and skin structure: Staphylococcus, non-penicillinase producing; Streptococcus; E. coli (see section 5.1 Pharmacodynamic Properties - Microbiology). Respiratory (acute and chronic): H. influenzae; Streptococcus; Strep. pneumoniae; Staphylococcus, nonpenicillinase producing; E. coli (see section 5.1 Pharmacodynamic Properties - Microbiology). Genitourinary tract (complicated and uncomplicated, acute and chronic): E. coli (see section 5.1 Pharmacodynamic Properties - Microbiology), P. mirabilis and Strep. faecalis. Gonorrhoea: N. gonorrhoeae (nonpenicillinase producing). Prophylaxis of endocarditis: Amoxycillin may be used for the prophylaxis of bacterial endocarditis in individuals at particular risk, such as those with a prosthetic heart valve or those who have previously had endocarditis.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on July, 1 2025. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
This medicine is generally considered safe during pregnancy if taken as directed. During pregnancy, you should discuss your medicine use with your doctor or pharmacist.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
INDICATIONS: It is indicated for the treatment of the following infections due to susceptible strains of sensitive organisms. Note. Therapy should be guided by bacteriological studies, including sensitivity tests, and by clinical response. However, in emergency cases where the causative organism has not been identified, therapy with amoxycillin may be useful. Clinical judgement will decide whether combination with another antibiotic would provide a sufficiently broad spectrum of activity pending sensitivity test results. Skin and skin structure: Staphylococcus, non-penicillinase producing; Streptococcus; E. coli (see section 5.1 Pharmacodynamic Properties - Microbiology). Respiratory (acute and chronic): H. influenzae; Streptococcus; Strep. pneumoniae; Staphylococcus, nonpenicillinase producing; E. coli (see section 5.1 Pharmacodynamic Properties - Microbiology). Genitourinary tract (complicated and uncomplicated, acute and chronic): E. coli (see section 5.1 Pharmacodynamic Properties - Microbiology), P. mirabilis and Strep. faecalis. Gonorrhoea: N.gonorrhoeae (nonpenicillinase producing). Prophylaxis of endocarditis: Amoxycillin may be used for the prophylaxis of bacterial endocarditis in individuals at particular risk, such as those with a prosthetic heart valve or those who have previously had endocarditis.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on July, 1 2025. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
This medicine is generally considered safe during pregnancy if taken as directed. During pregnancy, you should discuss your medicine use with your doctor or pharmacist.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Government Accredited with over 140 information partners
We are a government-funded service, providing quality, approved health information and advice
Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing
connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and
present.
